BENDAMUSTINE AND PREDNISONE IN COMBINATION WITH BORTEZOMIB (BPV) IN THE TREATMENT OF PATIENTS WITH NEWLY DIAGNOSED/UNTREATED MULTIPLE MYELOMA

被引：0
|
作者：
Poenisch, W. [1 ]
Holzvogt, B. [1 ]
Ploetze, M. [1 ]
Andrea, M. [1 ]
Lange, T. [1 ]
Niederwieser, D. [1 ]
机构：
[1] Univ Leipzig, D-04109 Leipzig, Germany
来源：
HAEMATOLOGICA | 2014年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P961
引用
收藏
页码：362 / 363
页数：2
相关论文
共 50 条
  • [31] COMBINATION THERAPY BASED ON BORTEZOMIB FOR PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
    Cai, C.
    He, J.
    Yang, Y.
    Han, H.
    Zheng, G.
    Zheng, W.
    Wei, W.
    Wu, W.
    Ye, Y.
    Shi, S.
    Xie, X.
    Li, L.
    Zhang, Z.
    Huang, H.
    Huang, H.
    Zhen, Z.
    [J]. HAEMATOLOGICA, 2012, 97 : 611 - 611
  • [32] Subcutaneous Administration of Bortezomib in Combination with Thalidomide and Dexamethasone for Treatment of Newly Diagnosed Multiple Myeloma Patients
    Wu, Shenghao
    Zheng, Cuiping
    Chen, Songyan
    Cai, Xiaoping
    Shi, Yuejian
    Lin, Bijing
    Chen, Yuemiao
    [J]. BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [33] First-line therapy with Bendamustine/Prednisone/Bortezomib (BPV) for non-transplant eligible symptomatic multiple myeloma patients
    Knauf, W.
    Dingeldein, G.
    Schlag, R.
    Welslau, M.
    Kunz, C.
    Moehler, T.
    Habermehl, C.
    Goldschmidt, H.
    Raab, M-S
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 188 - 188
  • [34] Bortezomib in combination with bendamustine and preduisone in the treatment of patients with refractory/relapsed multiple myeloma
    Poenisch, Wolfram
    Bourgeois, Malvina
    Wang, Song-Yau
    Heyn, Simone F.
    Jaekel, Nadja
    Braunert, Leanthe
    Rohrberg, Robert
    Hurtz, Hans Juergen
    Hoffmann, Franz Albert
    Schwarzer, Andreas
    Becker, Cornelia
    Al Ali, Haifa
    Niederwieser, Dietger W.
    [J]. BLOOD, 2007, 110 (11) : 799A - 800A
  • [35] Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma
    Richardson, Paul G.
    Weller, Edie
    Lonial, Sagar
    Jakubowiak, Andrzej J.
    Jagannath, Sundar
    Raje, Noopur S.
    Avigan, David E.
    Xie, Wanling
    Ghobrial, Irene M.
    Schlossman, Robert L.
    Mazumder, Amitabha
    Munshi, Nikhil C.
    Vesole, David H.
    Joyce, Robin
    Kaufman, Jonathan L.
    Doss, Deborah
    Warren, Diane L.
    Lunde, Laura E.
    Kaster, Sarah
    DeLaney, Carol
    Hideshima, Teru
    Mitsiades, Constantine S.
    Knight, Robert
    Esseltine, Dixie-Lee
    Anderson, Kenneth C.
    [J]. BLOOD, 2010, 116 (05) : 679 - 686
  • [36] Combination chemotherapy with bortezomib, bendamustine and prednisone for patients with refractory/relapsed multiple myeloma:: An unicentric retrospective trial
    Poenisch, W.
    Bourgeois, M.
    Wang, S. Y.
    Heyn, S.
    Jaekel, N.
    Braunert, L.
    Pfannes, R.
    Nehring, C.
    Nehring, C.
    Becker, C.
    Becker, C.
    Al Ali, H.
    Hensel, G.
    Niederwieser, D.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 432 - 432
  • [37] A prospective study of bortezomib in combination with melphalan and prednisone for patients with previously untreated multiple myeloma.
    Gasparetto, C
    Keogh, GP
    Gockerman, JP
    Horwitz, M
    Moore, JO
    DeCastro, C
    Diehl, L
    Davis, P
    Chao, N
    Rizzieri, DA
    [J]. BLOOD, 2005, 106 (11) : 379B - 379B
  • [38] Bortezomib in newly diagnosed multiple myeloma
    James R. Berenson
    [J]. Nature Reviews Clinical Oncology, 2009, 6 : 255 - 256
  • [39] Bortezomib in newly diagnosed multiple myeloma
    Berenson, James R.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (05) : 255 - 256
  • [40] BORTEZOMIB-MELPHALAN-PREDNISONE VERSUS MP AS INITIAL TREATMENT FOR VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
    Kim, M. K.
    Kim, K.
    Yoon, D. H.
    Suh, C.
    Moon, J. H.
    Lee, Y. J.
    Lee, J. H.
    Jung, S. -H.
    Kim, H. J.
    Bae, S. H.
    Kim, J. S.
    Lee, J. -O.
    Eom, H. S.
    Lee, W. -S.
    Kang, H. J.
    Mun, Y. -C.
    Do, Y. R.
    Hyun, M. S.
    [J]. HAEMATOLOGICA, 2017, 102 : 793 - 793
12345